A Conflict of Interest (COI) arises when an individual or institution has a relationship, whether personal or otherwise, that has the potential to compromise or interfere with their professional objectivity or judgment regarding related issues. A COI can be categorized as actual if a real relationship exists, or apparent if there is a potential for a relationship that could be inferred. It is the responsibility of the Editors, Associate Editors, Editorial Board members, authors, and reviewers of the Indo American Journal of Pharmaceutical Research (IAJPR) to disclose both actual and apparent Conflicts of Interest to ensure appropriate management and mitigation.

IAJPR implements procedures to regularly obtain information on potential conflicts of interest from all Editors and Associate Editors. This information is collected annually or upon appointment and includes details such as editorial roles with related or competing journals, institutional affiliations, and frequent collaborators. Editors are responsible for managing their own conflicts of interest as well as those of their Associate Editors, staff, authors, reviewers, and Editorial Board members. They maintain an updated summary of relevant interests (financial, academic, and other) for all editorial staff and board members, with updates occurring at least annually. Submissions from Editors, Editorial Board members, or employees are handled to ensure that the review process remains anonymous, with no access to review details beyond the anonymous reviews and decisions.